New York & Long Island Roundup Lawyers
Monsanto’s Development of Roundup
Glysophate is used in more than 160 countries, with more than 1.4 billion pounds applied each year. The Environmental Protection Agency (EPA) estimates that approximately 100 million pounds of glysophate are used on farms and lawns in the United States every year.
In 2015, Monsanto made over $4 billion in sales and nearly $2 billion in gross profits from its herbicide products, particularly, Roundup. In 2018, the German pharmaceutical mega company, Bayer, acquired Monsanto for $63 billion.
Monsanto’s Failure to Warn Consumers of Roundup’s Risks
In May 1985, a toxicology branch of the EPA classified glysophate as a possible human carcinogen. By 2015, the World Health Organization’s International Agency for Research on Cancer (IARC) determined that glysophate is carcinogenic and could lead to the development of non-Hodkin’s lymphoma. The IARC published an assessment stating glysophate can cause serious, and even fatal, illnesses when it is inhaled or absorbed through the skin. In April 2019, the U.S. Department of Health & Human Services released a study concluding that glysophate exposure increased the risk of developing non-Hodgkin’s lymphoma and multiple myeloma.
Unfortunately, in January 2020, the EPA refused to classify glysophate as dangerous despite the concerns of the WHO, environmental and consumer watchdog groups, and juries in numerous Roundup lawsuits. Following the EPA’s decision, one public interest group, U.S. PIRG, stated that instead of relying on the independent, peer-reviewed research that led the WHO to declare glysophate dangerous, the EPA “places greater emphasis on evidence from studies submitted by companies who sell glysophate-based herbicides to fulfill regulatory requirements.”
Despite the growing science about the risks associated with Roundup, Monsanto still fails to warn consumers about these risks on its bottling or packaging.
Roundup Cancer Injuries
- Non-Hodgkin’s lymphoma (NHL)
- Lymphocytic lymphoma
- Chronic lymphocytic lymphoma (CLL)
- B-cell lymphome
- T-cell lymphoma
- Hairy cell lymphoma
- Mulitple myeloma
So far, three Roundup cases have resulted in substantial verdicts for the injured plaintiffs. The first two trials resulted in verdicts of $289 million and $80 million. The third trial ended in a verdict for the plaintiff of $2 billion. Bayer, which acquired Monsanto, has set aside $16 billion to cover settlements of pending claims.
Though Bayer told investors in November 2021 that the company had reached tentative settlement agreements in roughly 98,000 Roundup lawsuits, accounting for nearly 80% of all pending Roundup cases. This still leaves nearly 30,000 active Roundup lawsuits that remain unsettled, and new cases continue to be filed on a regular basis as more individuals are diagnosed with injuries associated with Roundup use. Moreover, due to the length of time it may take for Roundup users to develop lymphoma, Bayer could be facing a steady stream of new Roundup lawsuits for years.
If you or someone you know used Roundup and was diagnosed with lymphoma, you may be entitled to significant compensation for your injuries. This includes reimbursement of your medical expenses, lost wages, pain and suffering, disability and permanent injury, and punitive damages.
To speak with an experienced product liability attorney, contact Lewis Saul & Associates, P.C. at (877) LAW-SUIT or (877) 529-7848.